Marius Vantler
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Hematopoietic PI3Kδ deficiency aggravates murine atherosclerosis through impairment of Tregs.
Journal: JCI insight
Published: October 11, 2021
Stamp2 Protects From Maladaptive Structural Remodeling and Systolic Dysfunction in Post-Ischemic Hearts by Attenuating Neutrophil Activation.
Journal: Frontiers in immunology
Published: April 28, 2021
Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension.
Journal: Cardiovascular research
Published: September 08, 2020
The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
Journal: Basic research in cardiology
Published: August 20, 2020
Disrupted PI3K subunit p110α signaling protects against pulmonary hypertension and reverses established disease in rodents.
Journal: The Journal of clinical investigation
Published: February 03, 2020
Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
Journal: Herz
Published: March 09, 2019
Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 26, 2014
Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 21, 2014
Imatinib mesylate for the treatment of pulmonary arterial hypertension.
Journal: Expert opinion on investigational drugs
Published: November 15, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026